Agilent Technologies, Signature Genomic Laboratories Announce Long-Term Supply Agreement for Oligo Microarrays

19-May-2008

Agilent Technologies Inc. and Signature Genomic Laboratories LLC announced they have signed a long-term supply agreement in which Agilent will supply custom oligonucleotide microarrays to Signature and its customers based on the Signature-designed SignatureChip Oligo Solution (SignatureChipOS). Terms of the agreement were not disclosed.

The SignatureChipOS is designed for the detection of chromosome abnormalities in individuals with mental retardation/developmental delay, autism and congenital anomalies. The 105,000-feature, 60-mer microarray covers more than 150 syndromes, the subtelomeric and pericentromeric regions, and more than 500 genes in important developmental pathways.

"We're very pleased about this agreement, which is the latest example of how the marketplace is recognizing the value of our highly flexible, high-quality custom oligonucleotide microarray production capability," said Yvonne Linney, Ph.D., Agilent vice president and general manager, Genomics. "We're delighted to work with Signature Genomic Laboratories, which specializes in microarray technology and is an innovative leader in microarray testing."

Other news from the department business & finance

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy